查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576812

基因分析市场：按技术、应用、最终用户、产品类型、工作流程划分 - 2025-2030 年全球预测

Genetic Analysis Market by Technology (Capillary Electrophoresis, CRISPR, Mass Spectrometry), Application (Agricultural Genetics, Animal Genetics, Clinical Diagnostics), End User, Product, Sample Type, Workflow - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，基因分析市值为102.4亿美元，预计到2024年将达到109.4亿美元，复合年增长率为6.90%，到2030年将达到163.4亿美元。

遗传分析是透过研究 DNA、RNA 和蛋白质来了解基因的结构和功能，在医疗保健、农业和生物技术领域发挥至关重要的作用。作为精准医学的基石，它可以根据个人的遗传特征提供量身定制的治疗方法。遗传分析的需求源自于能够深入了解遗传疾病、促进药物开发和优化农业生产，从而解决医疗保健和粮食安全的重要挑战。全球遗传分析市场受到技术进步、基因组序列测定成本降低以及对研发的日益关注的显着影响。新兴的基因组学市场预计将大大受益于 CRISPR 技术和次世代定序等技术创新，为相关人员提供投资和扩大在这些高成长领域的足迹的机会。然而，市场面临伦理问题、资料隐私问题以及基因资料的高度复杂性等挑战，阻碍了广泛采用。此外，缺乏严格的法律规范和标准化通讯协定也阻碍了市场的成长。儘管存在这些挑战，但透过与研究机构和医疗保健提供者合作开发综合遗传资料库和分析平台，仍有很大的扩展机会。具有巨大潜力的创新领域包括生物资讯学、个人化基因治疗和合成生物学，这些领域有望促进疾病预防和介入策略的突破。市场相关人员应专注于利用人工智慧和机器学习进行资料分析和改进预测基因组学模型。为了最大限度地提高成长前景，公司应主动应对监管环境，确保合规性，并解决与使用遗传资料相关的道德问题。透过专注于这些策略重点，公司可以利用基因分析的变革力量来塑造未来的医疗保健和农业范例。

主要市场统计
基准年[2023] 102.4亿美元
预测年份 [2024] 109.4亿美元
预测年份 [2030] 163.4亿美元
复合年增长率（%） 6.90%

市场动态：快速发展的基因分析市场的关键市场洞察

供需的动态交互作用正在改变基因分析市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大遗传分析在个人化医疗和标靶治疗中的作用
    • 政府对基因组研究和公共卫生计画的倡议和资助
    • 学术机构与生技公司合作促进基因研究
    • 消费者对消费者基因检测服务的兴趣日益浓厚，以深入了解家族历史和健康状况
  • 市场限制因素
    • 人们越来越担心基因检测结果的变异性和准确性
    • 由于技术的快速进步和主要企业之间的激烈竞争，市场进入障碍
  • 市场机会
    • 扩大基因检测在农业的应用，以促进作物改良和害虫抗性
    • 开发用于药物发现和个人化治疗计划的基因分析工具
    • 利用遗传见解进行精密农业和永续农业实践
  • 市场挑战
    • 将遗传分析与现有医疗保健系统整合的复杂性、资料互通性问题
    • 遗传分析领域的专业知识和劳动力有限影响市场成长

波特五力：驾驭基因分析市场的策略工具

波特的五力架构是了解基因分析市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解遗传分析市场的外部影响

外部宏观环境因素在塑造基因分析市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因分析市场的竞争状况

遗传分析市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵遗传分析市场供应商绩效评估

FPNV定位矩阵是评估基因分析市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製基因分析市场的成功之路

基因分析市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大遗传分析在个人化医疗和标靶治疗中的作用
      • 政府对基因组研究和公共卫生计画的倡议和资助
      • 学术机构和生物技术公司合作推进基因研究
      • 消费者对消费者基因检测服务的兴趣日益浓厚，以深入了解血统和健康状况
    • 抑制因素
      • 人们对基因检测结果的变异性和准确性的担忧日益增加
      • 由于技术的快速进步和主要参与者之间的激烈竞争导致市场进入障碍
    • 机会
      • 扩大基因检测在农业的应用，以促进作物改良和害虫抗性
      • 开发用于药物发现和个人化治疗计划的基因分析工具
      • 利用遗传知识进行精密农业和永续农业实践
    • 任务
      • 将遗传分析与现有医疗保健系统整合的复杂性和资料互通性问题
      • 遗传分析领域的专业知识和劳动力有限影响市场成长
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 基因分析市场：依技术分类

  • 毛细管电泳
  • 更脆
  • 质谱分析
  • 微阵列
  • 次世代定序
  • 聚合酵素链锁反应
  • 聚合酵素链锁反应(PCR)
    • 数位PCR
    • 即时PCR
  • 单细胞基因体学

第七章 基因分析市场：依应用分类

  • 农业遗传学
  • 动物遗传学
  • 临床诊断
    • 癌症诊断
    • 遗传疾病诊断
    • 感染疾病
  • 法医学
  • 製药/生物技术
  • 调查

第八章 基因分析市场：依最终使用者分类

  • 诊断实验室
  • 法医学研究所
  • 医院/诊所
  • 製药和生物技术公司
  • 研究中心和学术机构

第九章基因分析市场：副产品

  • 装置
  • 试剂/耗材
  • 软体和服务

第10章按样本类型分類的基因分析市场

  • 血
  • 骨
  • 唾液
  • 组织

第十一章基因分析市场：依工作流程

  • 资料分析
  • 前序
  • 定序

第十二章北美和南美的基因分析市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太地区基因分析市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲基因分析市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C059E

The Genetic Analysis Market was valued at USD 10.24 billion in 2023, expected to reach USD 10.94 billion in 2024, and is projected to grow at a CAGR of 6.90%, to USD 16.34 billion by 2030.

Genetic analysis, which encompasses studying DNA, RNA, and proteins to understand genetic structures and functions, has a pivotal role across healthcare, agriculture, and biotechnology sectors, driving innovations in personalized medicine, disease diagnostics, and crop improvement. It serves as a cornerstone in precision medicine, enabling tailored therapeutic approaches based on individual genetic profiles. The necessity of genetic analysis arises from its ability to provide insights into genetic disorders, facilitate drug development, and optimize agricultural outputs, thereby addressing crucial healthcare and food security challenges. The global market for genetic analysis is influenced significantly by technological advancements, the decreasing cost of genome sequencing, and a rising focus on research and development. Emerging markets in genomics are expected to benefit greatly from innovations such as CRISPR technology and next-generation sequencing, offering opportunities for stakeholders to expand their footprints by investing in these high-growth areas. However, the market faces challenges such as ethical concerns, data privacy issues, and the high complexity of genetic data which can hinder widespread adoption. Additionally, stringent regulatory frameworks and a lack of standardized protocols pose obstacles to market growth. Despite these challenges, there are substantial opportunities for business expansion through collaborations with research institutions and healthcare providers, aimed at developing comprehensive genetic databases and analytics platforms. Innovation areas with vast potential include bioinformatics, personalized gene therapies, and synthetic biology, which promise to catalyze breakthroughs in disease prevention and intervention strategies. Market players should focus on leveraging AI and machine learning for data analysis to refine predictive models in genomics. To maximize growth prospects, companies should navigate the regulatory landscape proactively, ensuring compliance and addressing ethical concerns related to genetic data usage. By focusing on these strategic priorities, businesses can harness the transformative power of genetic analysis in shaping future healthcare and agricultural paradigms.

KEY MARKET STATISTICS
Base Year [2023] USD 10.24 billion
Estimated Year [2024] USD 10.94 billion
Forecast Year [2030] USD 16.34 billion
CAGR (%) 6.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genetic Analysis Market

The Genetic Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expanding role of genetic analysis in personalized healthcare and targeted therapies
    • Government initiatives and funding support for genomic research and public health programs
    • Collaboration between academic institutions and biotech companies fostering genetic research
    • Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
  • Market Restraints
    • Growing concerns regarding the variability and accuracy of genetic testing results
    • Barriers to market entry due to rapid technological advancement and intense competition among key players
  • Market Opportunities
    • Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
    • Development of genetic analysis tools for drug discovery and personalized treatment plans
    • Utilization of genetic insights for precision farming and sustainable agricultural practices
  • Market Challenges
    • Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
    • Limited expertise and workforce in the field of genetic analysis impacting market growth

Porter's Five Forces: A Strategic Tool for Navigating the Genetic Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genetic Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genetic Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genetic Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genetic Analysis Market

A detailed market share analysis in the Genetic Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genetic Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genetic Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genetic Analysis Market

A strategic analysis of the Genetic Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Analysis Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc., BGI Group, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Genewiz, Inc., Genomic Health, Inc., Guardant Health, Inc., Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Personalis, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Capillary Electrophoresis, CRISPR, Mass Spectrometry, Microarray, Next-Generation Sequencing, Polymerase Chain Reaction, Polymerase Chain Reaction (PCR), and Single-Cell Genomics. The Polymerase Chain Reaction (PCR) is further studied across Digital PCR and Real-Time PCR.
  • Based on Application, market is studied across Agricultural Genetics, Animal Genetics, Clinical Diagnostics, Forensic Science, Pharmaceutical & Biotechnology, and Research. The Clinical Diagnostics is further studied across Cancer Diagnostics, Genetic Disease Diagnostics, and Infectious Diseases.
  • Based on End User, market is studied across Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic Institutions.
  • Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Sample Type, market is studied across Blood, Bone, Saliva, and Tissue.
  • Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding role of genetic analysis in personalized healthcare and targeted therapies
      • 5.1.1.2. Government initiatives and funding support for genomic research and public health programs
      • 5.1.1.3. Collaboration between academic institutions and biotech companies fostering genetic research
      • 5.1.1.4. Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
    • 5.1.2. Restraints
      • 5.1.2.1. Growing concerns regarding the variability and accuracy of genetic testing results
      • 5.1.2.2. Barriers to market entry due to rapid technological advancement and intense competition among key players
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
      • 5.1.3.2. Development of genetic analysis tools for drug discovery and personalized treatment plans
      • 5.1.3.3. Utilization of genetic insights for precision farming and sustainable agricultural practices
    • 5.1.4. Challenges
      • 5.1.4.1. Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
      • 5.1.4.2. Limited expertise and workforce in the field of genetic analysis impacting market growth
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genetic Analysis Market, by Technology

  • 6.1. Introduction
  • 6.2. Capillary Electrophoresis
  • 6.3. CRISPR
  • 6.4. Mass Spectrometry
  • 6.5. Microarray
  • 6.6. Next-Generation Sequencing
  • 6.7. Polymerase Chain Reaction
  • 6.8. Polymerase Chain Reaction (PCR)
    • 6.8.1. Digital PCR
    • 6.8.2. Real-Time PCR
  • 6.9. Single-Cell Genomics

7. Genetic Analysis Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural Genetics
  • 7.3. Animal Genetics
  • 7.4. Clinical Diagnostics
    • 7.4.1. Cancer Diagnostics
    • 7.4.2. Genetic Disease Diagnostics
    • 7.4.3. Infectious Diseases
  • 7.5. Forensic Science
  • 7.6. Pharmaceutical & Biotechnology
  • 7.7. Research

8. Genetic Analysis Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Forensic Laboratories
  • 8.4. Hospitals & Clinics
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Centers & Academic Institutions

9. Genetic Analysis Market, by Product

  • 9.1. Introduction
  • 9.2. Instruments
  • 9.3. Reagents & Consumables
  • 9.4. Software & Services

10. Genetic Analysis Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
  • 10.3. Bone
  • 10.4. Saliva
  • 10.5. Tissue

11. Genetic Analysis Market, by Workflow

  • 11.1. Introduction
  • 11.2. Data Analysis
  • 11.3. Pre-Sequencing
  • 11.4. Sequencing

12. Americas Genetic Analysis Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Genetic Analysis Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Analysis Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe, Inc.
  • 2. Adaptive Biotechnologies Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Beckman Coulter, Inc.
  • 5. BGI Group
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Eurofins Scientific
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Genewiz, Inc.
  • 10. Genomic Health, Inc.
  • 11. Guardant Health, Inc.
  • 12. Illumina, Inc.
  • 13. Invitae Corporation
  • 14. Myriad Genetics, Inc.
  • 15. Oxford Nanopore Technologies plc
  • 16. Pacific Biosciences of California, Inc.
  • 17. PerkinElmer, Inc.
  • 18. Personalis, Inc.
  • 19. QIAGEN N.V.
  • 20. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENETIC ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENETIC ANALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. GENETIC ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. GENETIC ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENETIC ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENETIC ANALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SINGLE-CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY AGRICULTURAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY GENETIC DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 76. CANADA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 118. CHINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 126. INDIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 263. ITALY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. NORWAY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. NORWAY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. NORWAY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 295. POLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 297. POLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. POLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. POLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. POLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 303. QATAR GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 305. QATAR GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 306. QATAR GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. QATAR GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. QATAR GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 313. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 337. SPAIN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 338. SPAIN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 339. SPAIN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. SPAIN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 343. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 345. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 346. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 347. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 352. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND GENETIC ANALYSIS